Anand Mehra's Net Worth

$4.26 Million

Estimate Recalculated Nov 7, 2024 11:51AM EST

Who is Anand Mehra?

Anand Mehra has an estimated net worth of $4.26 Million. This is based on reported shares across multiple companies, which include MARINUS PHARMACEUTICALS INC, HISTOGENICS CORP, Merus N.V., Aclaris Therapeutics, Inc., AERIE PHARMACEUTICALS INC, Spark Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Iterum Therapeutics plc, Galera Therapeutics, Inc., Principia Biopharma Inc., NextCure, Inc., Mirna Therapeutics, Inc., aTYR PHARMA INC, Versartis, Inc., and ALIMERA SCIENCES INC.

SEC CIK

Anand Mehra's CIK is 0001590102

Past Insider Trading and Trends

2020 was Anand Mehra's most active year for acquiring shares with 5 total transactions. Anand Mehra's most active month to acquire stocks was the month of May. 2019 was Anand Mehra's most active year for disposing of shares, totalling 6 transactions. Anand Mehra's most active month to dispose stocks was the month of May. 2021 saw Anand Mehra paying a total of $268,298.24 for 36,358 shares, this is the most they've acquired in one year. In 2019 Anand Mehra cashed out on 92,906 shares for a total of $4,603,243.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $1.3911

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-35.31%
-750.68K
$1.39
-$1,042,698.68
1.38M
Oct 20
Form 4
—
0
—
—
0
Aug 3
Form 4
—
0
—
—
0
Jul 20
Form 4
—
0
—
—
0
Sep 30
Form 4
+71.72%
2.13M
$8.00
$6,005,464.00
5.09M
Aug 5
Form 3
—
0
—
—
0
No matching records found

HISTOGENICS CORP (OCGN) Snapshot price: $1.13

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.08M
$10.86
—
2.08M
Dec 8
Form 3
—
0
—
—
0
No matching records found

AERIE PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-38.75%
-297.07K
$18.61
-$13,658,095.29
469.59K
Apr 14 - Apr 15
Form 4
∞
1.7K
—
—
1.7K
Apr 10
Form 4
-51.06%
-800.00K
$26.00
-$20,800,000.00
766.66K
Nov 25
Form 4
-39.15%
-1.01M
$24.91
-$24,208,330.17
1.57M
Jul 9 - Jul 10
Form 4
—
0
—
—
0
Jun 11
Form 4
-6.94%
-191.98K
—
—
2.57M
Jun 2
Form 4
-10.48%
-323.93K
$16.00
-$5,182,912.00
2.77M
May 22
Form 4
∞
3.09M
$6.49
—
3.09M
Oct 25
Form 3
—
0
—
—
0
No matching records found

Entasis Therapeutics Holdings Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+300.87%
1.16M
$15.00
—
1.54M
Sep 28
Form 3
—
0
—
—
0
No matching records found

Iterum Therapeutics plc (ITRM) Snapshot price: $1.12

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.73M
$13.00
—
1.73M
May 30
Form 3
—
0
—
—
0
No matching records found